Experimental Hematology
Volume 38, Issue 6 , Pages 437-445, June 2010

Hematopoietic effect of water-soluble polysaccharides from Angelica sinensis on mice with acute blood loss

  • Pei-Jou Liu

      Affiliations

    • Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan
  • ,
  • Wen-Ting Hsieh

      Affiliations

    • Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan
  • ,
  • Shih-Hao Huang

      Affiliations

    • Department of Food and Beverage Management, Taipei College of Marine Technology, Taipei, Taiwan
  • ,
  • Hui-Fen Liao

      Affiliations

    • Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan
  • ,
  • Been-Huang Chiang

      Affiliations

    • Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationOffprint requests to: Been-Huang Chiang, Ph.D., Institute of Food Science and Technology, National Taiwan University, 1, Section 4, Roosevelt Road, Taipei, Taiwan, ROC

Received 14 October 2009; received in revised form 1 March 2010; accepted 16 March 2010. published online 29 March 2010.

Objective

To assess the hematopoietic effects of Angelica sinensis and to investigate the possible mechanism related to its hematopoietic activity.

Materials and Methods

The crude extract of Angelica sinensis (AS) was separated into two fractions, polysaccharides (ASPS) and small molecular weight compounds. The AS, ASPS, and small molecular weight compounds were incubated with mice spleen cells to obtain conditioned mediums, and then their hematopoietic activities were evaluated by granulocyte macrophage (GM) colony-forming assay in vitro. During in vivo test, we used mice that were bled approximately 0.5 mL by retro-orbital bleeding at day 0 as our anemia model.

Results

We found that polysaccharide (ASPS) was the major component responsible for the hematopoietic effect of Angelica sinensis. The hematopoietic activity was through the stimulation of secretion of interleukin-6 and GM colony-stimulating factor, and the amounts of these hematopoietic growth factors secreted, in general, agreed with the number of GM colony formations. Administration of low-dose ASPS (2.3 mg ASPS/kg body weight per day) could significantly accelerate the recovery of hemoglobin level of the blood-loss mice to its original value, as compared to the control (p < 0.05). Moreover, the colony-forming ability of bone marrow cells that were removed from mice that received ASPS was also markedly increased (p < 0.05) during ex vivo test.

Conclusions

Results of this study demonstrated the potential of ASPS for treatment of anemia.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00103-7

doi:10.1016/j.exphem.2010.03.012

Experimental Hematology
Volume 38, Issue 6 , Pages 437-445, June 2010